Literature DB >> 21974725

Transepithelial, Topography-guided Ablation in the Treatment of Visual Disturbances in LASIK Flap or Interface Complications.

Xiangjun Chen1, Aleksandar Stojanovic, Wen Zhou, Tor Paaske Utheim, Filip Stojanovic, Qinmei Wang.   

Abstract

PURPOSE: To evaluate the efficacy and safety of a single-step, transepithelial, topography-guided surface ablation in the treatment of visual disturbances including irregular astigmatism and light scattering caused by LASIK flap or interface complications.
METHODS: Seventeen eyes of 16 patients with LASIK flap or interface complications and central residual stromal thickness ≥300 μm were treated with a topography-guided custom transepithelial "no touch" (cTEN) technique using the iVIS Suite 1-kHz excimer laser (iVIS Technology). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refraction, corneal irregularity, ocular higher order aberrations (HOAs), and visual symptoms were analyzed.
RESULTS: Mean 15.9±11.0 months after surgery, mean UDVA improved from 20/87 to 20/25. Mean CDVA improved from 20/28 to 20/19 (P<.001), with 64.7% of eyes gaining two or more lines of CDVA. Mean corneal irregularity index decreased from 25.82 to 20.36 μm (P=.009). Mean root-mean-square (RMS) of total HOAs decreased from 1.30 to 0.49 (P=.042), whereas RMS of the odd-order (3rd and 5th) and even-order (4th and 6th) HOAs decreased from 0.85 to 0.38 (P=.001) and 0.43 to 0.24 (P=.036), respectively. All patients claimed their visual symptoms were better (8 eyes) or cured (9 eyes).
CONCLUSIONS: Corneal regularization and removal of the underlying flap or interface pathology by cTEN ablation appears to be an effective treatment for LASIK flap or interface complications associated with visually disturbing irregular astigmatism and light scattering in cases with sufficient residual stromal thickness. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21974725     DOI: 10.3928/1081597X-20110926-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  8 in total

1.  Using LaserSight Astrapro Planner 2.2 Z software in corneal topography-guided laser in situ keratomileusis for myopia with asymmetric corneal shape.

Authors:  Bing Liu; Wei Chen; De-Wang Shao; Hua Wang; Hai-Xia Ru; Min Zhang; Ying Wang; Chun-Yan Yang
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

2.  One-step transepithelial topography-guided ablation in the treatment of myopic astigmatism.

Authors:  Aleksandar Stojanovic; Shihao Chen; Xiangjun Chen; Filip Stojanovic; Jia Zhang; Ting Zhang; Tor Paaske Utheim
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

3.  Comparison of corneal epithelial and stromal thickness distributions between eyes with keratoconus and healthy eyes with corneal astigmatism ≥ 2.0 D.

Authors:  Wen Zhou; Aleksandar Stojanovic
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

4.  Rescue of primary incomplete microkeratome flap with secondary femtosecond laser flap in LASIK.

Authors:  E A Razgulyaeva
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-23

Review 5.  Topography-guided treatment in regular and irregular corneas.

Authors:  Shreyas Ramamurthy; B Soundarya; Gitansha S Sachdev
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

6.  Post-Laser In Situ Keratomileusis Epithelial Ingrowth: Treatment, Recurrence, and Long-Term Results.

Authors:  Nilufer Yesilirmak; Priyanka Chhadva; Florence Cabot; Anat Galor; Sonia H Yoo
Journal:  Cornea       Date:  2018-12       Impact factor: 3.152

7.  Visual and Refractive Outcomes of Topography-guided Laser-assisted In Situ Keratomileusis in Virgin Eyes.

Authors:  Sharif Hashmani; Nauman Hashmani; Husna Haroon; Yusra Hashmi
Journal:  Cureus       Date:  2018-01-31

8.  Fine tuning of the default depth and rate of ablation of the epithelium in customized trans-epithelial one-step superficial refractive excimer laser ablation.

Authors:  Michael Goggin; Peter Stewart; Vikija Andersons; Giuseppe Criscenti
Journal:  Eye Vis (Lond)       Date:  2019-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.